230 related articles for article (PubMed ID: 23936038)
21. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.
Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H
Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046
[TBL] [Abstract][Full Text] [Related]
22. Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.
Jung JW; Yoon SM; Kim S; Jeon YH; Yoon BH; Yang SG; Kim MK; Choe S; Kuo MM
Oncotarget; 2016 Nov; 7(45):73754-73768. PubMed ID: 27650540
[TBL] [Abstract][Full Text] [Related]
23. Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
Navarro-Villarán E; de la Cruz-Ojeda P; Contreras L; González R; Negrete M; Rodríguez-Hernández MA; Marín-Gómez LM; Álamo-Martínez JM; Calvo A; Gómez-Bravo MA; de la Cruz J; Padillo J; Muntané J
Cell Physiol Biochem; 2020 May; 54(3):457-473. PubMed ID: 32369692
[TBL] [Abstract][Full Text] [Related]
24. BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression.
Ren W; Sun X; Wang K; Feng H; Liu Y; Fei C; Wan S; Wang W; Luo J; Shi Q; Tang M; Zuo G; Weng Y; He T; Zhang Y
Mol Biol Rep; 2014 Mar; 41(3):1373-83. PubMed ID: 24413988
[TBL] [Abstract][Full Text] [Related]
25. DLL4/Notch1 and BMP9 Interdependent Signaling Induces Human Endothelial Cell Quiescence via P27KIP1 and Thrombospondin-1.
Rostama B; Turner JE; Seavey GT; Norton CR; Gridley T; Vary CP; Liaw L
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2626-37. PubMed ID: 26471266
[TBL] [Abstract][Full Text] [Related]
26. BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells.
Maegdefrau U; Bosserhoff AK
Exp Mol Pathol; 2012 Feb; 92(1):74-81. PubMed ID: 22024355
[TBL] [Abstract][Full Text] [Related]
27. WSS25 inhibits growth of xenografted hepatocellular cancer cells in nude mice by disrupting angiogenesis via blocking bone morphogenetic protein (BMP)/Smad/Id1 signaling.
Qiu H; Yang B; Pei ZC; Zhang Z; Ding K
J Biol Chem; 2010 Oct; 285(42):32638-46. PubMed ID: 20679340
[TBL] [Abstract][Full Text] [Related]
28. Bone morphogenetic protein-9 is a circulating vascular quiescence factor.
David L; Mallet C; Keramidas M; Lamandé N; Gasc JM; Dupuis-Girod S; Plauchu H; Feige JJ; Bailly S
Circ Res; 2008 Apr; 102(8):914-22. PubMed ID: 18309101
[TBL] [Abstract][Full Text] [Related]
29. Developmental pattern of expression of BMP receptors and Smads and activation of Smad1 and Smad5 by BMP9 in mouse basal forebrain.
Lopez-Coviella I; Mellott TM; Kovacheva VP; Berse B; Slack BE; Zemelko V; Schnitzler A; Blusztajn JK
Brain Res; 2006 May; 1088(1):49-56. PubMed ID: 16626664
[TBL] [Abstract][Full Text] [Related]
30. Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.
Fernando J; Sancho P; Fernández-Rodriguez CM; Lledó JL; Caja L; Campbell JS; Fausto N; Fabregat I
J Cell Physiol; 2012 Apr; 227(4):1319-25. PubMed ID: 21604268
[TBL] [Abstract][Full Text] [Related]
31. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
[TBL] [Abstract][Full Text] [Related]
32. Impact of selective anti-BMP9 treatment on tumor cells and tumor angiogenesis.
Brand V; Lehmann C; Umkehrer C; Bissinger S; Thier M; de Wouters M; Raemsch R; Jucknischke U; Haas A; Breuer S; Birzele F; Racek T; Reis M; Lorenzon E; Herting F; Stürzl M; Lorenz S; Kienast Y
Mol Oncol; 2016 Dec; 10(10):1603-1620. PubMed ID: 28949445
[TBL] [Abstract][Full Text] [Related]
33. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.
Tillet E; Ouarné M; Desroches-Castan A; Mallet C; Subileau M; Didier R; Lioutsko A; Belthier G; Feige JJ; Bailly S
J Biol Chem; 2018 Jul; 293(28):10963-10974. PubMed ID: 29789425
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor 2 inhibits bone morphogenetic protein 9-induced osteogenic differentiation of mesenchymal stem cells by repressing Smads signaling and subsequently reducing Smads dependent up-regulation of ALK1 and ALK2.
Song T; Wang W; Xu J; Zhao D; Dong Q; Li L; Yang X; Duan X; Liang Y; Xiao Y; Wang J; He J; Tang M; Wang J; Luo J
Int J Biochem Cell Biol; 2013 Aug; 45(8):1639-46. PubMed ID: 23680673
[TBL] [Abstract][Full Text] [Related]
35. Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines.
Baiz D; Dapas B; Farra R; Scaggiante B; Pozzato G; Zanconati F; Fiotti N; Consoloni L; Chiaretti S; Grassi G
World J Gastroenterol; 2014 Jan; 20(3):795-803. PubMed ID: 24574752
[TBL] [Abstract][Full Text] [Related]
36. New insights into BMP9 signaling in liver diseases.
Jiang QQ; Liu BB; Xu KS
Mol Cell Biochem; 2021 Oct; 476(10):3591-3600. PubMed ID: 34019202
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of TGF-β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines.
Dzieran J; Fabian J; Feng T; Coulouarn C; Ilkavets I; Kyselova A; Breuhahn K; Dooley S; Meindl-Beinker NM
PLoS One; 2013; 8(8):e72252. PubMed ID: 23991075
[TBL] [Abstract][Full Text] [Related]
38. Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin.
Wei W; Chua MS; Grepper S; So SK
Mol Cancer; 2011 Feb; 10():16. PubMed ID: 21314951
[TBL] [Abstract][Full Text] [Related]
39. Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways.
Zhang H; Li JC; Luo H; Zhao L; Zhang ZD; Shen XF
Phytomedicine; 2019 Jun; 59():152759. PubMed ID: 31004883
[TBL] [Abstract][Full Text] [Related]
40. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.
Chen J; Zhu H; Liu Q; Ning D; Zhang Z; Zhang L; Mo J; Du P; Liu X; Song S; Fan Y; Liang H; Liu J; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Jun; 38(1):273. PubMed ID: 31228948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
